Implementation of a reference standard and proficiency testing programme by the World Wide Antimalarial Resistance Network (WWARN)

Malaria Journal

Volumn 9, Issue 1, 2010, Pages

  Lourens, Chris ^a   Watkins, William M ^a,c   Barnes, Karen I ^a,d   Sibley, Carol H ^a,e   Guerin, Philippe J ^a,c   White, Nicholas J ^a,b,c   Lindegardh, Niklas ^a,b,c  

^a Sorbonne Paris Cité   (United Kingdom)

^b MAHIDOL UNIVERSITY   (Thailand)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; DRUG METABOLITE;

ACCURACY; ARTICLE; DRUG EFFICACY; DRUG SAFETY; IN VITRO STUDY; LABORATORY; MALARIA; QUALITY CONTROL; STANDARD; DRUG EFFECT; DRUG SENSITIVITY; HEALTH CARE QUALITY; HUMAN; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; METHODOLOGY; PARASITOLOGY; PLASMODIUM;

ANTIMALARIALS; HUMANS; INTERNATIONAL COOPERATION; MALARIA; PARASITIC SENSITIVITY TESTS; PLASMODIUM; QUALITY ASSURANCE, HEALTH CARE; REFERENCE STANDARDS;

EID: 78650468843     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-9-375     Document Type: Article

References (18)

1. WWARN - World-wide antimalarial resistance network. http://www.wwarn.org
2. Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. KI Barnes F Little PJ Smith A Evans WM Watkins NJ White, Clin Pharmacol Ther 2006 80 582 596 10.1016/j.clpt.2006.08.016 17178260
3. Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria. J Tarning R McGready N Lindegardh EA Ashley M Pimanpanarak B Kamanikom A Annerberg NP Day K Stepniewska P Singhasivanon NJ White F Nosten, Antimicrob Agents Chemother 2009 53 3837 3846 10.1128/AAC.00195-09 19564366
4. The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria. R McGready K Stepniewska N Lindegardh EA Ashley Y La P Singhasivanon NJ White F Nosten, Eur J Clin Pharmacol 2006 62 1021 1031 10.1007/s00228-006-0199-7 17053895
5. Pharmacokinetics of chloroquine and mono-desethylchloroquine in pregnancy. HA Karunajeewa S Salman I Mueller F Baiwog S Gomorrai I Law M Page-Sharp S Rogerson P Siba KF Ilett TM Davis, Antimicrob Agents Chemother 2010 54 1186 1192 10.1128/AAC.01269-09 20086162
6. Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria. F Ezzet M van Vugt F Nosten S Looareesuwan NJ White, Antimicrob Agents Chemother 2000 44 697 704 10.1128/AAC.44.3.697-704.2000 10681341
7. Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance. JA Simpson ER Watkins RN Price L Aarons DE Kyle NJ White, Antimicrob Agents Chemother 2000 44 3414 3424 10.1128/AAC.44.12.3414-3424.2000 11083649
8. Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria. RN Price AC Uhlemann M van Vugt A Brockman R Hutagalung S Nair D Nash P Singhasivanon TJ Anderson S Krishna NJ White F Nosten, Clin Infect Dis 2006 42 1570 1577 10.1086/503423 16652314
9. Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. RN Price AR Hasugian A Ratcliff H Siswantoro HL Purba E Kenangalem N Lindegardh P Penttinen F Laihad EP Ebsworth NM Anstey E Tjitra, Antimicrob Agents Chemother 2007 51 4090 4097 10.1128/AAC.00486-07 17846129
10. World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility. DJ Bacon R Jambou T Fandeur J Le Bras C Wongsrichanalai MM Fukuda P Ringwald CH Sibley DE Kyle, Malar J 2007 6 120 10.1186/1475-2875-6-120 17822533
11. A network to monitor antimalarial drug resistance: a plan for moving forward. CH Sibley KI Barnes WM Watkins CV Plowe, Trends Parasitol 2008 24 43 48 10.1016/j.pt.2007.09.008 18042432
12. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. KI Barnes N Lindegardh O Ogundahunsi P Olliaro CV Plowe M Randrianarivelojosia GO Gbotosho WM Watkins CH Sibley NJ White, Malar J 2007 6 122 10.1186/1475-2875-6-122 17822537
13. The International Harmonized Protocol for the Proficiency testing of Analytical Chemistry Laboratories. Pure Appl Chem 2006 78 145 196 10.1351/pac200678010145
14. Set-up and evaluation of interlaboratory studies. Y Vander Heyden J Smeyers-Verbeke, J Chromatogr A 2007 1158 158 167 10.1016/j.chroma.2007.02.053 17339041
15. Quartz - Forensic blood toxicology proficiency testing scheme. LGC Standards Proficiency Testing
16. Inter-laboratory studies in analytical chemistry. E Hund DL Massart J Smeyers-Verbeke, Analytica Chimica Acta 2000 423 145 165 10.1016/S0003-2670(00) 01115-6
17. Laboratory Accreditation Program (LAP) Proficiency Testing Response Requirements and Definitions. The College of American Pathologists (CAP)
18. Regulatory observations in bioanalytical determinations. CT Viswanathan, Bioanalysis 2010 2 1325 1329 10.4155/bio.10.85 21083243